FAM215A

ncRNA information

ncRNA name

FAM215A

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

LAMP2

Cancer information

Cancer name

Liver Cancer

Cancer site

qRT-PCR,Western blot

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

lncRNA FAM215A, is highly expressed in HCC, where it interacts with and stabilizes LAMP2 to increase tumor progression while decreasing doxorubicin sensitivity

Tissue resource

human hepatocellular carcinoma specimens

human hepatocellular carcinoma cell lines Hep3B

human hepatocellular carcinoma cell lines Mahlavu

human hepatocellular carcinoma cell lines J7

Experiment

None


Institute

Chang Gung Memorial Hospital

Country

China

Continent

Asia